Gunther Birznieks

2019

In 2019, Gunther Birznieks earned a total compensation of $2M as Senior Vice President, Business Development at Vanda Pharmaceuticals, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$180,765
Option Awards$805,077
Salary$386,250
Stock Awards$618,600
Other$20,129
Total$2,010,821

Birznieks received $805.1K in option awards, accounting for 40% of the total pay in 2019.

Birznieks also received $180.8K in non-equity incentive plan, $386.3K in salary, $618.6K in stock awards and $20.1K in other compensation.

Rankings

In 2019, Gunther Birznieks' compensation ranked 5,892nd out of 13,971 executives tracked by ExecPay. In other words, Birznieks earned more than 57.8% of executives.

ClassificationRankingPercentile
All
5,892
out of 13,971
58th
Division
Manufacturing
2,211
out of 5,701
61st
Major group
Chemicals And Allied Products
802
out of 2,200
64th
Industry group
Drugs
677
out of 1,886
64th
Industry
Pharmaceutical Preparations
499
out of 1,398
64th
Source: SEC filing on April 22, 2020.

Birznieks' colleagues

We found four more compensation records of executives who worked with Gunther Birznieks at Vanda Pharmaceuticals in 2019.

2019

Mihael Polymeropoulos

Vanda Pharmaceuticals

Chief Executive Officer

2019

Gian Reverberi

Vanda Pharmaceuticals

Former Senior Vice President, Chief Commercial Officer

2019

James Kelly

Vanda Pharmaceuticals

Chief Financial Officer

2019

Timothy Williams

Vanda Pharmaceuticals

General Counsel

News

You may also like